The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nadel, B.
Right arrow Articles by Feeney, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nadel, B.
Right arrow Articles by Feeney, A. J.
The Journal of Immunology, 1998, 161: 6068-6073.
Copyright © 1998 by The American Association of Immunologists

Decreased Frequency of Rearrangement due to the Synergistic Effect of Nucleotide Changes in the Heptamer and Nonamer of the Recombination Signal Sequence of the V{kappa} Gene A2b, Which Is Associated with Increased Susceptibility of Navajos to Haemophilus influenzae Type b Disease1

Bertrand Nadel, Alan Tang, Geanncarlo Lugo, Victoria Love, Guia Escuro and Ann J. Feeney2

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Navajos and genetically related populations have a 10-fold increased incidence of Haemophilus influenzae type b (Hib) disease compared with control populations. The V{kappa} gene A2 is used to encode the majority of anti-Hib Abs, and these are the highest affinity anti-Hib Abs. Navajos carry a different allele of the A2 gene segment (A2b) that is defective in its ability to undergo V-J recombination. The A2b allele has only three nucleotide changes from the commonly occurring A2a allele, two of which could potentially affect its ability to recombine. In this study we used two independent in vitro assays to test whether the nucleotide change found in the A2b promoter and/or in the A2b recombination signal sequence (RSS) might be responsible for the decrease in recombination frequency observed in vivo. Using a luciferase reporter gene assay, we found no significant difference between A2a and A2b promoter activities. However, the competition recombination substrate assay showed a 4.5-fold reduction in the relative frequency of recombination of the A2b RSS compared with A2a. We show that this decreased frequency is due to a synergistic effect of the unique nucleotide change present in the heptamer of the A2b RSS and the shared nucleotide change present in the nonamer of both A2b and A2a. This in vitro relative frequency of rearrangement is not significantly different from that observed in vivo; therefore, the A2b RSS is probably the factor associated with the increased susceptibility to Hib disease among individuals carrying the A2b allele.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Haemophilus influenzae type b (Hib)3 is the major cause of bacterial meningitis in infants (1). The Ab response to Hib is very pauciclonal, and all Abs sequenced to date were derived from the combination of only approximately four related VHIII genes (2). The light chain contribution is much more diverse, with over nine genes from the {kappa} and {lambda} loci being observed (2). Nonetheless, among Abs mounted in response to both Hib infection and polysaccharide vaccination, the A2 light chain has been shown to be by far the most frequently used, and it presents no consistent somatic mutations. In addition, the A2-containing Abs show the highest avidity for Hib (3). Together, these data suggest that the presence of a functional A2 gene in the human {kappa} locus is a key element for an efficient anti-Hib response.

Navajos and genetically related populations descending from the Na-dene group have a 10-fold increased incidence of Hib disease compared with control populations (4, 5, 6). Previously, we hypothesized that a polymorphism in the A2 gene that impaired its expression might lead to the observed increase disease susceptibility; therefore, we analyzed DNA from healthy Navajo and control individuals. Over half of the Navajos studied, but only one control individual, had a new allele of A2, which we termed A2b (the allele corresponding to the published sequence is termed A2a) (7). The analysis of the relative frequency of recombination of nonproductive A2 rearrangements in A2a/b heterozygous Navajos showed a dramatic decrease in A2b rearrangements compared with A2a, suggesting that the A2b allele is defective in its ability to undergo rearrangement (7). The sequence of the A2b allele shows three nucleotide changes from the published A2a sequence: a one-nucleotide change in the recombination signal sequence (RSS), a one-nucleotide substitution in the promoter 16 bp 5' of the octamer, and a one-nucleotide change in the FR2 (7).

RSSs are necessary cis elements of the V(D)J recombination process and flank each gene segment to be joined (8, 9). Each RSS consists of two blocks of sequences, a highly conserved heptamer (consensus: CACAGTG) and a less well conserved nonamer (consensus: ACAAAAACC), separated by a spacer of a conserved length of 12 or 23 bp, but nonconserved sequence. Changes in the first three nucleotides of the heptamer have been shown to be extremely deleterious, whereas changes in the other four bases have more various effects (8, 9, 10). In the nonamer, the presence of three consecutive A residues is necessary for efficient recombination (10). The A2b RSS has a 1-bp change in the sixth nucleotide of the heptamer (CACAGAG), and both the A2a and A2b alleles have a substitution in their nonamer (ACAGAAACC) (7, 11). Therefore, although these two positions are not commonly thought to be of critical importance for recombination, we proposed that the effect of the change in the heptamer or the combined effects of the two changes in the heptamer and nonamer were likely to account for the severe decrease in the frequency of recombination observed in vivo for the A2b gene segment (7). On the other hand, accessibility of the various V, D, and J loci is a prerequisite for the initiation of recombination (12, 13, 14). Transcription of unrearranged gene segments (germline transcripts) occurs just before rearrangement, and this germline transcription has been hypothesized to play a role in locus accessibility, although it is still not clear whether transcription of unrearranged segments is responsible for, or is a consequence of, the open chromatin structure at those loci. Therefore, the C->A change in the A2b promoter, which is located 16 bp upstream of the octamer and which creates a CCAAT box, is also a potential candidate to influence the ability of the A2b allele to undergo rearrangement.

In this study we used two in vitro assays to test separately the potential effect of each of the promoter and RSS substitutions of the A2b allele. Levels of transcription of the A2a and A2b promoter were analyzed in a luciferase assay, and the individual and combined effects of the nucleotide changes in the A2b RSS on the recombination frequency were assessed in a modified recombination substrate assay. While the sequence change in the A2b promoter showed no significant effect on transcription levels compared with the A2a promoter, there was a 4.5-fold reduction in the relative frequency of recombination of the A2b gene segment compared with that of A2a as determined by the recombination substrate experiments. This indicates that the A2b RSS is at least in a large part responsible for the defective recombination of the A2b gene segment, and consequently, the RSS change may play a significant role in the increased susceptibility to Hib infection among A2b homozygous Navajos.

Thus, a single base change in a position commonly thought to have a modest effect on RSS function can significantly affect the in vivo repertoire and can have severe disease-associated biologic consequences.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Competition plasmids

The principle and construction of our recombination substrates have been previously described (15). Competition substrates were derived from the recombination substrate Vß8.2-Jß1 by multistep cloning (Fig. 1GoA) (16). Two V{kappa} segments were inserted on the 5' side of the termination signal and are therefore competing for rearrangement with the unique J{kappa}1 segment located on the 3' side of the termination signal. Coding ends flanked by their RSSs were obtained by PCR from human genomic DNA, with oligonucleotide primers containing the appropriate restriction sites to enable insertion into the recombination substrate. Subsequent modifications of the RSSs were introduced by PCR from the appropriate clones using mismatched primers. PCR primers were located over 100 bp upstream the RSS and 10–100 bp downstream the RSS. The two RSS flanking the V{kappa} segments on the 5' side of the plasmids were therefore about 150 bp apart (Comp12, Comp19, Comp16, Comp11, Comp33, and Comp35) or about 240 bp apart (Comp4 and Comp8). All PCR primer sequences are available by request.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 1. A, Competition substrate map. Sequences of the J{kappa}1 coding end and of the internal and external A2b coding ends flanked by their RSS (black triangles) are shown. Coding ends are in bold type, and heptamer and nonamers are boxed. B, BamHI; M, MluI; N, NotI; Sc, SacII, S, SalI; Sp, SpeI. B, PCR screening assay used to analyze rearrangement status. The locations of the PCR primers (AF74, P4) and the sizes of the PCR products are shown.

 
Recombination assay

18.8 Abelson-Moloney leukemia virus transformed pre-B cells (20 x 106) were transiently transfected with 20 µg of purified plasmid (Qiagen, Chatsworth, CA) by electroporation (960 µF, 0.3 kV) and resuspended in 10 ml of RPMI 1640 supplemented with 5 x 10-5 M 2-ME, 10% FCS, 2 mM glutamine, and 1 mM caffeine. After 48 h, plasmids were recovered from transfected cells by alkaline lysis, followed by DpnI/SpeI digestion. Digested plasmids were then electroporated into JM109 Escherichia coli and plated on plates containing ampicillin (100 µg/ml) and chloramphenicol (5 µg/ml). PCR screening assays were performed from the colonies by resuspending each chloramphenicol-resistant bacterial colony directly in the PCR reagent mixture and amplifying with AF74 and P4 primers (Fig. 1GoB) for 30 cycles (1 min at 94°C, 1 min at 55°C, and 2 min at 72°C). PCR products from each colony were analyzed by agarose gel electrophoresis for the size of the product (see Fig. 1Go). Some of the clones were simultaneously miniprepped, and their rearrangement status was confirmed by sequencing. No more than 40 colonies were analyzed from each transfection, and several transfections were performed with each construct.

Luciferase constructs

Three sets of constructs were made containing the A2a or A2b promoters. The enhancerless constructs were made in the pGL3-Basic luciferase reporter gene vector (Promega, Madison, WI). The other sets contained either the human {kappa} intronic enhancer (iE{kappa}) or the murine IgH intronic enhancer (Eµ) inserted into the pGL2-Basic luciferase vector. All enhancer and promoter fragments were generated by PCR. The entire promoter fragments and the core portions of the enhancer constructs were sequenced to ensure the absence of Taq-introduced errors. The A2a and A2b promoters included the region from 18–312 bp of the A2 sequence (GenBank accession no. M311952). This segment includes 200 bp 5' of the octamer and extends to 12 bp 5' of the start of the leader exon. The promoters were inserted into the XhoI and HindIII sites in the pGL vectors via sites engineered into the PCR primers. The enhancers were cloned downstream of the luciferase gene in the BamHI site. The human {kappa} enhancer included the region between nucleotides 3598–4089 from GenBank sequence X67858. The heavy chain intronic enhancer includes bp 21–734 of GenBank sequence M12827.

Luciferase assay

Constructs were transfected into the human cell lines representing mature B cells (Daudi) and pre-B cells (BLIN-1) (17). Transfections were performed as described by Fulton et al. (18). Briefly, 1 million cells were transiently transfected with 1 µg of purified luciferase reporter plasmids using the DEAE-dextran method. The cells were then cultured in 1.2 ml of RPMI 1640 supplemented with 5 x 10-5 M 2-ME, 10% FCS, and 2 mM glutamine for 24 h, harvested, washed, and lysed in cell culture lysis reagent (Promega). Twenty microliters of the extract was mixed with 100 µl of the luciferase assay reagent (Promega), and luciferase activity was measured for 30 s in a Monolight 2010 Luminometer (Analytical Luminescence Laboratory, San Diego, CA). For each experiment, three to five replicate wells were transfected for each construct. In each experiment, the corresponding vector without any promoter fragment was also transfected as a negative control for background levels of transcription. Transfection without any plasmid was used to detect background luciferase activity, which was minimal. Promoterless pGL2 vectors with either enhancer gave luciferase activity that was essentially the same as the background luminescence. On the other hand, the pGL3-Basic vectors had a significantly higher background. Therefore, in Table IVGo, the average luciferase units obtained after transfection with the appropriate promoterless construct was subtracted from the average luciferase units obtained with the promoter-containing construct. The ratio of the net increase in luciferase activity with the A2a promoter to that obtained with the A2b promoter was then determined. Each construct was transfected in 6–12 separate experiments, and the SE for each construct is shown.


View this table:
[in this window]
[in a new window]
 
Table IV. Promoter activity of the A2a vs A2b promoters in luciferase reporter constructs1

 

    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Competition recombination substrates

To analyze the role of the RSSs flanking various gene segments in the frequency of recombination, we designed a series of recombination substrates in which two V{kappa} segments flanked by their RSSs are in competition for rearrangement with a J{kappa}1 segment (Fig. 1GoA). Since both segments are on the same plasmid, this design controls for variation in transfection efficiency and thus provides very accurate relative frequencies of recombination. The status of the recombination was assessed by PCR, using primers located upstream and downstream of the most external gene segments (AF74 and P4, Fig. 1GoB). In this assay, recombination of the external V{kappa} gene segment with J{kappa}1 generates a 370-bp PCR product, while recombination of the internal V{kappa} gene generates a 520- to 630-bp PCR product depending on the gene segments (see Materials and Methods). Rare background unrearranged clones can be observed as 1360- to 1580-bp PCR products. The reliability of this assay was confirmed by simultaneously sequencing random clones.

A prerequisite of this study using competition substrates was to determine whether the internal or external location of the V{kappa} gene segments would have an influence on the frequency of recombination. To do so, we analyzed the relative frequency of recombination of a substrate containing the same gene segment at both the external and internal locations. Comp12 contains the same A2b segment at the external and internal positions, and the relative frequency of recombination of the external vs internal segments is 49:51% (Table IGo). This indicates that the location of the various segments has no effect on their relative frequency of recombination in our assay.


View this table:
[in this window]
[in a new window]
 
Table I. Relative recombination frequencies of A2a and A2b in competition substrates

 
Role of RSS in the decreased frequency of recombination of the A2b allele

To assess the role of the variant heptamer A2b RSS in the decreased frequency of recombination of the A2b gene segment compared with A2a, we constructed a series of competition substrates containing various combinations of those two segments. Comp4 contains an external A2a segment and an internal A2b segment, while Comp8 is the reverse, with an external A2b segment and an internal A2a segment (Table IGo). In both plasmids similar results were found, with 79–84% of the recombination happening at the A2a locus regardless of its position in the plasmid. Fisher’s exact test shows that the distribution of relative frequency of recombination of A2a vs A2b is not significantly different in Comp4 and Comp8 (p = 0.3), but is significantly different from that in the control substrate, Comp12 (p < 0.0001). Since these results confirm the previous observation that the locations of the gene segments in the competition plasmids do not influence the outcome of the recombination, we combined the results obtained for Comp4 and Comp8 to obtain a more precise estimate of the relative frequencies of recombination of A2a vs A2b. Table IIGo shows that of 416 clones, 82 ± 3.7% had recombined the A2a segment, and only 18 ± 3.7% had recombined the A2b segment. Thus, these results show that the single base change in the sixth position of the heptamer of the A2b segment results in a 4.5-fold difference in its relative frequency of rearrangement compared with that of A2a.


View this table:
[in this window]
[in a new window]
 
Table II. Comparison of relative recombination frequencies of A2a and A2b in vivo and in vitro

 
These relative frequencies are similar to our previous in vivo results, where we found that of 28 nonproductive rearrangements from A2a/b heterozygous individuals, 25 (89%) were from the A2a allele, and 3 (11%) were from the A2b allele (7) (Table IIGo). Although our in vivo data showed a greater disparity between the relative recombination frequencies, Fisher’s exact test showed that this in vivo distribution of the relative frequency of A2a/A2b recombination was not significantly different from the results found in vitro (p = 0.44). Since our in vitro sample size was much larger than that in vivo, the ratio of 82:18 may reflect more accurately the relative frequency of A2a/A2b recombination. These results indicate that the T->A substitution in the sixth position of the heptamer of the A2b RSS is sufficient to account for the decreased frequency of recombination observed in vivo for the A2b allele compared with A2a.

Individual and synergistic effects of the substitutions in the heptamer and nonamer on the frequency of recombination

In addition to the T->A change in the A2b heptamer, both the A2a and A2b alleles had an A->G substitution in their nonamer compared with consensus RSS motifs (Table IGo). Hence, the decreased frequency of recombination observed in A2b could be either the result of the change in the heptamer alone or a synergistic effect of the combination of changes in the heptamer and nonamer. To test whether the combined effect of the nucleotide substitution in the heptamer and nonamer is similar to the combined effect of each substitution individually, we designed new constructs containing various combinations of each substitution and compared them to an A2 segment flanked by a consensus RSS. Comp19 shows the relative frequency of recombination of the A2a/A18 RSS vs a consensus RSS, and therefore the impact of the nonamer substitution alone, while Comp33 shows the impact of the heptamer substitution alone (Table IIIGo). (A2a and A18 are duplicated genes, and have identical RSS sequences and very similar coding end sequences, the only differences between the terminal portion of the coding ends being 9, 17, and 24 bp 5' of the RSS. Both are equivalently amplified by our PCR primers, and these minor coding region differences are unlikely to be significant.) The change in the nonamer alone results in a relative frequency of recombination of 28 ± 7.2% compared with a consensus nonamer (Comp19), equivalent to a ratio of 2.6, and the change in the heptamer alone results in a relative frequency of recombination of 27 ± 8% compared with a consensus heptamer (Comp33), also with a ratio of 2.7. If the effects of the nucleotide changes in the heptamer and nonamer are cumulative, we would expect that an RSS containing both changes (A2b) would rearrange sevenfold less well (2.6 x 2.7) than a consensus RSS. Comp35 shows that the relative frequency of recombination of the A2b RSS vs a consensus RSS is 7 ± 4.2%, or a ratio of 13.3 (Table IIIGo). The relative frequency of recombination is therefore decreased twofold from the expected cumulative effects of the two nucleotide changes. This indicates that the effects of the nucleotide changes in the heptamer and nonamer decrease the frequency of recombination in a synergistic manner.


View this table:
[in this window]
[in a new window]
 
Table III. Relative recombination frequencies of A2b heptamer or nonamer changes

 
Role of the A2a and A2b promoter regions in the decreased frequency of recombination of the A2b allele

To assess the potential role of the C->A nucleotide substitution present in the A2b promoter, the transcription activity of the A2a and A2b promoter regions was tested in a luciferase reporter gene assay. Since the relevant transcription that might affect recombination is that of the unrearranged V{kappa} genes that occurs in pre-B cells before L chain rearrangement, we transfected BLIN-1, an acute leukemic pre-B cell line (17). Because Ig transcription activity is lower in pre-B cells than in B cells, we also transfected Daudi cells, a mature B cell lymphoma line. Three sets of vectors were made (pGL3/enhancerless, pGL2/Eµ, and pGL2/iE{kappa}). pGL2/Eµ and pGL2/iE{kappa} contain the murine IgH intronic enhancer and the human {kappa} intronic enhancer, respectively. Since the enhancers are very distant from the V gene promoters before rearrangement, germline transcription is thought to be enhancer independent or at least independent of any enhancer yet described. Therefore, in the first set of vectors we placed the V{kappa} promoters in the enhancerless pGL3-Basic luciferase reporter vector. pGL3-Basic was chosen over the closely related pGL2-Basic, since no promoter activity was observed when strong V gene promoters were placed in pGL2-Basic without enhancers (data not shown). pGL3-Basic is a more sensitive vector, although it has a higher background, and with this vector we were able to detect luciferase activity driven by these promoters in the absence of any enhancer.

The results are displayed in two ways. In Fig. 2Go, the black bars represent the average of the actual mean luciferase units for each construct from every experiment. These data also display the magnitude of the relative activities of the different constructs and their promoterless controls. Within each experiment, the replicate wells were extremely similar, but the magnitude of the maximal luciferase activity among experiments did vary significantly. Hence, the calculations in Table IVGo are the most valid for comparing the relative promoter values of A2a vs A2b. In these calculations, the net increase in luciferase activity over the background activity given by the appropriate promoterless construct was determined for each promoter-containing construct in each experiment. For each experiment, the ratio of this net luciferase activity of A2a to that for A2b was determined. The ratios from all of the experiments were averaged, and the SE was calculated.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 2. Luciferase activity of constructs with the A2a and A2b promoters and their promoterless control vectors. Results are the mean luciferase units obtained with each construct from all experiments.

 
The results presented in Table IVGo show that the transcription levels of the luciferase gene are somewhat reduced in enhancerless A2b/pGL3/- vector compared with those in the A2a/pGL3/- vector in the BLIN-1 pre-B cells, although they are essentially the same in Daudi cells. The A2a and A2b promoters were also placed into a pGL2 vector into which we had inserted 600 bp of the human {kappa} intronic enhancer (A2a/pGL2/iE{kappa}). The luciferase activity from this set of plasmids was low, however, and only minimal activity over background was obtained after transfection of BLIN-1 pre-B cells (data not shown). In the Daudi cells, the A2a promoter was somewhat better than A2b, although transcription levels were low for both (Fig. 2Go). The reason why the enhancer activity from this fragment was so low is not clear. Although we anticipated somewhat higher activity, this result was not totally unpredictable, as the activity of the murine {kappa} intronic enhancer in murine pre-B cells and B cells was previously shown to be low (18). In mature B cells, both iE{kappa} and 3'E{kappa} are needed for optimal activity. However, since we are primarily interested in the promoter activity in pre-B cells where the 3'E{kappa} is very weak and in which there is no synergy between the two enhancers, we did not create a double enhancer construct (18).

Since the activities of the promoters were so weak in the presence of iE{kappa}, we also made a third set of vectors in which the A2a and A2b promoters were placed into pGL2 vectors into which we had previously inserted the murine intronic enhancer (pGL2/Eµ). These vectors gave high promoter activity, and the A2a and A2b promoters showed equivalent activity in both pre-B cells and B cells (Table IVGo).

These results suggest that the nucleotide substitution in the A2b promoter region is minimally deleterious to the transcription activity in the absence of any enhancer or with the {kappa} enhancer and displays no difference in activity in the presence of the strong Eµ enhancer. These data strongly suggest that differential transcriptional activity is unlikely to be a major factor in the reduced rearrangement of A2b.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We previously showed that the frequency of recombination in vivo of the A2b allelic form of the A2 gene segment is dramatically decreased compared with that of the A2a allele (7). The A2b allele has only three base pair changes from the A2a allele, two of which could potentially affect its ability to recombine. In the present study we tested whether polymorphism in the RSS sequence flanking the A2b gene segment and/or polymorphism in the A2b promoter could be responsible for the inability of the A2b gene segment to rearrange as efficiently as the A2a gene segment. To test each possibility independently, we used two separate in vitro systems.

To test the role of the variant A2b RSS, we constructed a competition recombination substrate assay consisting of in vitro recombination of a plasmid containing the A2b and A2a gene segments in competition for rearrangement with the J{kappa}1 gene segment, and compared their relative frequencies of recombination. The results show that the single T to A substitution present at the sixth position of the A2b heptamer leads to a 4.5-fold decrease in the relative frequency of rearrangement of the A2b gene segment compared with that of A2a. These relative frequencies of recombination found in vitro (82:18) are similar to and not statistically significantly different from our previous in vivo observation (89:11) (7). Since our in vitro sample size is much larger than that in vivo, this may more accurately reflect the relative frequency of A2a vs A2b recombination and suggests that the substitution in the A2b RSS alone is sufficient to explain the decreased recombination rate observed for the A2b allele. Thus, this one-nucleotide change in the heptamer might be the main genetic factor responsible for higher susceptibility to Hib infection in populations carrying the A2b allele.

Changes in the heptamer and nonamer result in a broad range of deleterious effects on the recombination efficiency, depending on their nature and location (8, 9, 10). Some changes almost abolish recombination, while others have been described as more minor effects. Importantly, we show in this study that a four- to fivefold drop in the relative frequency of recombination, commonly considered a modest decrease, might, in fact, result in a dramatic under-representation of the gene segment in the primary B cell repertoire and eventually lead to a disease-associated inability to mount a specific Ab response. This suggests, therefore, that it may be important to consider the biologic effects of minor changes in the RSS in the light of these results.

In the study by Akamatsu et al. using a different recombination substrate system, an RSS with the same change in the sixth position of the heptamer as that present in A2b rearranged at 39.6 ± 5% the frequency of a consensus RSS (10). This corresponds to a 2.5-fold decrease or a (72:28%) relative frequency of recombination for the consensus RSS vs the RSS with the altered heptamer, respectively. The estimation of the effect of the T to A change in the heptamer in that report is therefore about 2-fold lower than that observed in this study between A2a and A2b (Table IGo, Comp4 and Comp8) and over 3 times lower than our in vivo observation (Table IIGo). Since the construct in Akamatsu et al. study contained the heptamer change in the context of a consensus nonamer, and since both A2a and A2b have an additional nucleotide change in the nonamer, one explanation for the apparent difference in results was that the effect of the nucleotide changes in the heptamer and nonamer in A2b would be synergistic, e.g., would be worse than a simple cumulative effect of each of the changes. We directly tested this hypothesis by comparing the individual and combined effects of the two substitutions in additional competition substrates, containing a consensus RSS as one of the two segments. In agreement with Akamatsu et al., we found that a T to A substitution at the sixth position of the heptamer leads to a 2.7-fold reduction of rearrangement (73:27%) compared with that of a consensus RSS. In addition, we found a similar 2.6-fold relative reduction for the A to G substitution at position 4 of the nonamer (72:28%), while Akamatsu et al. found a slightly more deleterious effect (79:21%, ratio 3.7). However, when both changes are present simultaneously in the RSS (A2b RSS), our results show a dramatic 13.3-fold decrease in recombination (93:7%) relative to the A2 RSS with consensus heptamer and nonamer, which is about 2-fold more than the product of each change individually. These results indicate a synergistic effect of the changes in the heptamer and nonamer of the A2b RSS.

Our results suggest that the effect on recombination of changes in one of the RSS motifs is dependent on the context of the other RSS motif. Recent DNA binding studies indicate that nonamer and heptamer motifs fulfill different primary functional roles during the first steps of the recombination (19, 20, 21). In these studies, the nonamer was revealed as the critical element for initial recognition and binding by RAG-1, while the heptamer was mainly involved in directing the cleavage step after engagement of the RAG-1/RAG-2 complex on the DNA, although it was also described to enhance RAG binding. Both nonamer and heptamer could therefore modulate the frequency of rearrangement, by controlling either the binding or the cleavage activity. Here, we show that changes in the heptamer and nonamer in the A2b RSS synergistically decrease the frequency of recombination, suggesting that the effect of the additional change in the A2b heptamer could be related to the destabilization of the RAG-1/2 complex, as a result of the poorer binding to the nonconsensus A2 nonamer.

We also tested whether the change in the promoter of the A2b gene, which creates a CCAAT element 14 bp 5' of the essential octamer, might have any effect on transcription. To mimic the transcription that occurs from unrearranged genes before V(D)J rearrangement and that is tightly correlated with accessibility for rearrangement (12, 13, 14), we established an assay in which we could measure luciferase activity in a construct in the absence of any enhancer. We also tested these promoters in the presence of two different enhancers. Our results show no significant difference between the two promoters, although the A2a promoter was slightly better in the absence of any enhancer or with the {kappa} enhancer. Thus, if germline transcription is required for rearrangement accessibility, then the A2b promoter change is unlikely to play any role in the reduced rearrangement potential of the A2b allele. However, the promoter may be involved in promoting chromatin restructuring to create accessibility of the downstream V gene independent of germline transcription. Thus, our results do not exclude the possibility that a CCAAT binding protein may bind to the A2b promoter and block the chromatin restructuring necessary for accessibility of the A2b gene.

In summary, these results show a 4.5-fold decrease in the relative frequency of recombination of the A2b segment compared with that of A2a. Moreover, we show a 13.3-fold decrease in the A2b segment compared with segments flanked by consensus RSSs. Together, these data indicate that the nucleotide variations from consensus in the heptamer and nonamer of A2b are synergistic, presumably by destabilizing the interaction of the RAG-1/RAG-2 complex with the RSS. Importantly, our results suggest that a 4- to 5-fold decrease in the relative recombination rate of the A2b gene segment is genetically associated with high susceptibility to Hib disease, suggesting that minor changes in the frequency of recombination of gene segments can have important biologic consequences.


    Acknowledgments
 
We gratefully acknowledge Dr. Tucker LeBien for providing the BLIN-1 cell line.


    Footnotes
 
1 This work was supported by U.S. Public Health Service Grant AI37098 from the National Institutes of Health, American Cancer Society California Division Fellowship 1-33-96B (to B.N.), and National Institutes of Health Training Grant T34GM08303 (to G.L. and V.L.). This is manuscript 11297-IMM from The Scripps Research Institute. Back

2 Address correspondence and reprint requests to Dr. Ann J. Feeney, The Scripps Research Institute, Department of Immunology IMM-22, 10550 North Torrey Pines Rd., La Jolla, CA 92037. E-mail address: Back

3 Abbreviations used in this paper: Hib, Haemophilus influenzae type b; RSS, recombination signal sequence; RAG-1, recombination-activating gene-1. Back

Received for publication May 18, 1998. Accepted for publication July 21, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Broome, C. V.. 1987. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr. Infect. Dis. J. 6:779.[Medline]
  2. Scott, M. G., H. G. Zachau, M. H. Nahm. 1992. The human antibody V region repertoire to the type B capsular polysaccharide of Haemophilus influenzae. Int. Rev. Immunol. 9:45.[Medline]
  3. Granoff, D. M., P. G. Shackelford, S. J. Holmes, T. C. V. S. Group, A. H. Lucas. 1993. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. J. Clin. Invest. 91:788.
  4. Coulehan, J. L., R. H. Michaels, C. Hallowell, R. Schults, T. K. Welty, J. S. C. Kuo. 1984. Epidemiology of Haemophilus influenzae type b disease among Navajo Indians. Pub. Health Rep. 99:404.[Medline]
  5. Ward, J. J., H. S. Margolis, M. K. Lum, D. W. Fraser, T. R. Bender. 1981. Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet 1:1281.[Medline]
  6. Losonsky, G. A., M. Santosham, V. M. Sehgal, A. Zwahlen, E. R. Moxon. 1985. Haemophilus influenzae disease in the White Mountain Apaches: molecular epidemiology of a high risk population. Pediatr. Infect. Dis. 3:539.
  7. Feeney, A. J., M. J. Atkinson, M. J. Cowan, G. Escuro, G. Lugo. 1996. A defective VkA2 allele in Navajos which may play a role in increased susceptibility to Haemophilus influenzae type b disease. J. Clin. Invest. 97:2277.[Medline]
  8. Akira, S., K. Okazaki, H. Sakano. 1987. Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining. Science 238:1134.[Abstract/Free Full Text]
  9. Hesse, J. E., M. R. Lieber, K. Mizuuchi, M. Gellert. 1989. V(D)J recombination: a functional definition of the joining signals. Genes Dev. 3:1053.[Abstract/Free Full Text]
  10. Akamatsu, Y., N. Tsurushita, F. Nagawa, M. Matsuoka, K. Okazaki, M. Imai, H. Sakano. 1994. Essential residues in V(D)J recombination signals. J. Immunol. 153:4520.[Abstract]
  11. Scott, M. G., D. L. Crimmins, D. W. McCourt, I. Zocher, R. Thiebe, H. G. Zachau, M. H. Nahm. 1989. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide III.A single VkII gene and one of several Jk genes are joined by an invariant arginine to form the most common L chain V region. J. Immunol. 143:4110.[Abstract]
  12. Yancopoulos, G. D., F. W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40:271.[Medline]
  13. Yancopoulos, G. D., F. W. Alt. 1986. Regulation of the assembly and expression of variable-region genes. Annu. Rev. Immunol. 4:339.[Medline]
  14. Schlissel, M. S., D. Baltimore. 1989. Activation of immunoglobulin {kappa} gene rearrangement correlates with induction of germline {kappa} gene transcription. Cell 58:1001.[Medline]
  15. Nadel, B., A. J. Feeney. 1997. Nucleotide deletion and P addition in V(D)J recombination: a determinant role of the coding-end sequence. Mol. Cell. Biol. 17:3768.[Abstract]
  16. Nadel, B., A. Tang, G. Escuro, G. Lugo, A. J. Feeney. 1998. Sequence of the spacer in the RSS affects V(D)J rearrangement frequency and correlates with non-random Vk usage in vivo. J. Exp. Med. 187:1495.[Abstract/Free Full Text]
  17. Wörmann, B., J. M. Anderson, J. A. Liberty, K. Gajl-Peczalska, R. D. Brunning, T. Silberman, D. C. Arthur, T. W. LeBien. 1989. Establishment of a leukemic cell model for studying human pre-B to B cell differentiation. J. Immunol. 142:110.[Abstract]
  18. Fulton, R., B. Van Ness. 1993. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res. 21:4941.[Abstract/Free Full Text]
  19. Difilippantonio, M. J., C. J. McMahan, Q. M. Eastman, E. Spanopoulou, D. G. Schatz. 1996. RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell 87:253.[Medline]
  20. Spanopoulou, E., F. Zaitseva, F.-H. Wang, S. Santagata, D. Baltimore, G. Panayotou. 1996. The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination. Cell 87:263.[Medline]
  21. Nagawa, F., K.-I. Ishiguro, A. Tsuboi, T. Yoshida, A. Ishikawa, T. Takemori, A. J. Otsuka, H. Sakano. 1998. Footprint analysis of the RAG protein recombination signal sequence complex for V(D)J recombination. Mol. Cell. Biol. 18:655.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
BloodHome page
A. Hadzidimitriou, N. Darzentas, F. Murray, T. Smilevska, E. Arvaniti, C. Tresoldi, A. Tsaftaris, N. Laoutaris, A. Anagnostopoulos, F. Davi, et al.
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
Blood, January 8, 2009; 113(2): 403 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang and P. C. Swanson
V(D)J Recombinase Binding and Cleavage of Cryptic Recombination Signal Sequences Identified from Lymphoid Malignancies
J. Biol. Chem., March 14, 2008; 283(11): 6717 - 6727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Montalbano, K. M. Ogwaro, A. Tang, A. G. W. Matthews, M. Larijani, M. A. Oettinger, and A. J. Feeney
V(D)J Recombination Frequencies Can Be Profoundly Affected by Changes in the Spacer Sequence
J. Immunol., November 15, 2003; 171(10): 5296 - 5304.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. E. Tillman, A. L. Wooley, B. Khor, T. D. Wehrly, C. A. Little, and B. P. Sleckman
Cutting Edge: Targeting of V{beta} to D{beta} Rearrangement by RSSs Can Be Mediated by the V(D)J Recombinase in the Absence of Additional Lymphoid-Specific Factors
J. Immunol., January 1, 2003; 170(1): 5 - 9.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Marculescu, T. Le, P. Simon, U. Jaeger, and B. Nadel
V(D)J-mediated Translocations in Lymphoid Neoplasms: A Functional Assessment of Genomic Instability by Cryptic Sites
J. Exp. Med., January 7, 2002; 195(1): 85 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Williams, A. Martinez, A. Montalbano, A. Tang, A. Mauhar, K. M. Ogwaro, D. Merz, C. Chevillard, R. Riblet, and A. J. Feeney
Unequal VH Gene Rearrangement Frequency Within the Large VH7183 Gene Family Is Not Due to Recombination Signal Sequence Variation, and Mapping of the Genes Shows a Bias of Rearrangement Based on Chromosomal Location
J. Immunol., July 1, 2001; 167(1): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Hougs, L. Juul, A. Svejgaard, and T. Barington
Structural Requirements of the Major Protective Antibody to Haemophilus influenzae Type b
Infect. Immun., May 1, 1999; 67(5): 2503 - 2514.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nadel, B.
Right arrow Articles by Feeney, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nadel, B.
Right arrow Articles by Feeney, A. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS